Arcadia Biosciences, Inc. (RKDA) Financials

RKDA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 23.5 million 8.1 million
2023-06-30 26.8 million 9.1 million
2023-03-31 30.4 million 13.7 million
2022-12-31 28.9 million 8.0 million

RKDA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -2.9 million 162000
2023-06-30 -4.8 million 199000
2023-03-31 -3.5 million 212000
2022-12-31 -2.4 million 209000

RKDA Net Income

No data available :(

RKDA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 15.7 million - 1.3 million
2023-06-30 18.5 million - 1.5 million
2023-03-31 23.0 million - 1.8 million
2022-12-31 20.6 million - 2.0 million

RKDA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 1.4 million
2023-06-30 1.4 million
2023-03-31 857572
2022-12-31 599389

RKDA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 305000 3.4 million -
2023-06-30 5000 391000 3.8 million -
2023-03-31 5000 359000 4.4 million -
2022-12-31 26000 500000 4.2 million -

RKDA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 1.6 million 1.1 million
2023-06-30 1.4 million 981000
2023-03-31 1.5 million 825000
2022-12-31 1.0 million 1.6 million

RKDA

Price: $2.09

52 week price:
1.89
7.81

Earnings Per Share: -21.41 USD

P/E Ratio: -0.12

Exchange: NCM

Sector: Consumer Defensive

Industry: Packaged Foods

Volume: 191500

Ebitda: -4.4 million

Market Capitalization: 2.3 million

Links: